Hunan Jiudian Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥8.09 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	17.40
Forward PE	11.48
Price to Sales TTM	CN¥2.67
Price to Book MRQ	CN¥3.03
Enterprise to Revenue	2.39
Enterprise to EBITDA	11.45

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	16.88%
Operating Margin	21.42%
Return on Assets TTM	10.42%
Return on Equity TTM	21.55%

Income Statement

Revenue TTM	CN¥3,035,809,536
Revenue per Share TTM	CN¥6.18
Quarterly Revenue Growth	17.80%
Gross Profit TTM	CN¥2,222,669,568
EBITDA	CN¥593,099,507
Net Income to Common TTM	CN¥512,483,424
Diluted EPS TTM	CN¥0.93
Quarterly Earnings Growth YoY	0.10%

Balance Sheet

Total Cash MRQ	CN¥819,058,496
Total Cash per Share MRQ	CN¥1.65
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	13.67
Current Ratio MRQ	5.68
Book Value per Share MRQ	CN¥5.34

Cash Flow

Operating Cash Flow TTM	CN¥655,497,216
Levered Free Cash Flow TTM	CN¥2,284,904

300705 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	496,194,320
Float Shares	265,137,806
Avg 10 Volume	16,194,593
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	47.21%
% Held by Institutions	12.03%

Stock Price Summary

Beta	0.47
Fifty Two Week Low	CN¥14.41
Fifty Two Week High	CN¥28.75
Fifty Two Week Change	-55.13%
Day 50 MA	CN¥15.98
Day 200 MA	CN¥18.95

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.25
Forward Annual Dividend Yield	7.74%
Trailing Annual Dividend Rate	CN¥0.31
Trailing Annual Dividend Yield	1.93%
Payout Ratio	34.15%
Dividend Date
Ex Dividend Date	2025-05-26
Last Split Factor
Last Split Date	2024-05-24